A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome
- PMID: 7783419
- DOI: 10.1038/ki.1995.170
A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome
Abstract
The X-linked Alport syndrome is associated with mutations and deletions in COL4A5 gene, one of six genes which constitute the alpha-chains of type IV collagen in basement membranes. The autosomal recessive form of Alport syndrome is characterized by mutations and deletions in the COL4A3 and COL4A4 genes. A fraction of Alport patients who undergo renal transplantation develop anti-glomerular basement membrane (GBM) nephritis, which results in loss of the renal allograft function. Recently, the target for alloantibodies from an X-linked Alport patient with complete COL4A5 gene deletion was determined to be the alpha 3 chain of type IV collagen. The present study characterized the post-transplant alloantibodies from an autosomal recessive Alport patient with anti-GBM glomerulonephritis and a COL4A3 gene mutation which predicted a loss of 85% of the alpha 3(IV) NC1 domain. The specificity of these new antibodies were studied using glomerular basement membrane constituents and recombinant type IV collagen domains. The results establish the target for the alloantibodies from an autosomal recessive Alport patient with COL4A3 deletion as principally the alpha 3(IV) collagen chain, similar to the post-transplant alloantibodies from X-linked Alport patients with COL4A5 gene deletions. The absence of alpha 3(IV) chain in the GBM of patients with both these forms of Alport syndrome, due either to a failure of synthesis or a failure of assembly, presumably leads to a loss of immunologic tolerance for the alpha 3(IV) NC1 domain in transplanted allografts.
Similar articles
-
COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.Kidney Int. 1994 Mar;45(3):721-6. doi: 10.1038/ki.1994.96. Kidney Int. 1994. PMID: 8196274
-
Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.Kidney Int. 1998 Mar;53(3):762-6. doi: 10.1046/j.1523-1755.1998.00794.x. Kidney Int. 1998. PMID: 9507224
-
The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.Kidney Int. 1992 Jul;42(1):179-87. doi: 10.1038/ki.1992.276. Kidney Int. 1992. PMID: 1635348
-
Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.Medicine (Baltimore). 1999 Sep;78(5):338-60. doi: 10.1097/00005792-199909000-00005. Medicine (Baltimore). 1999. PMID: 10499074 Review.
-
[Molecular genetics of Alport syndrome].Nihon Rinsho. 1992 Dec;50(12):3021-6. Nihon Rinsho. 1992. PMID: 1491454 Review. Japanese.
Cited by
-
Three-dimensional electron microscopy reveals the evolution of glomerular barrier injury.Sci Rep. 2016 Oct 11;6:35068. doi: 10.1038/srep35068. Sci Rep. 2016. PMID: 27725732 Free PMC article.
-
Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation.Int J Nephrol Renovasc Dis. 2018 Oct 16;11:267-270. doi: 10.2147/IJNRD.S150539. eCollection 2018. Int J Nephrol Renovasc Dis. 2018. PMID: 30410383 Free PMC article. Review.
-
Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis.J Clin Invest. 1997 May 15;99(10):2470-8. doi: 10.1172/JCI119431. J Clin Invest. 1997. PMID: 9153291 Free PMC article.
-
Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.J Clin Invest. 1997 Nov 1;100(9):2263-75. doi: 10.1172/JCI119764. J Clin Invest. 1997. PMID: 9410904 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
